cyproterone acetate has been researched along with androstane-3,17-diol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Rooy, HA; Ponjee, GA; Vader, HL | 1 |
| Giagulli, VA; Giorgino, R; Vermeulen, A | 1 |
| Cathelineau, G; Fiet, J; Hardy, N; Martineau, I; Vexiau, P; Vexiau-Robert, D; Villette, JM | 1 |
| Bartsch, W; Huang, JK; Voigt, KD | 1 |
| Brailly, S; Couzinet, B; Le Strat, N; Schaison, G | 1 |
| Rubens, R | 1 |
| Blaquier, JA; Tezón, JG | 1 |
| Geleijnse, JM; Giltay, EJ; Gooren, LJ; Schouten, EG; Stehouwer, CD; Verhoef, P | 1 |
2 trial(s) available for cyproterone acetate and androstane-3,17-diol
| Article | Year |
|---|---|
Comparative effects of cyproterone acetate or a long-acting gonadotropin-releasing hormone agonist in polycystic ovarian disease.
Topics: Adult; Androstane-3,17-diol; Androstenedione; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Estradiol; Estrone; Female; Gonadotropin-Releasing Hormone; Humans; Polycystic Ovary Syndrome; Testosterone; Triptorelin Pamoate | 1986 |
Oral and transdermal estrogens both lower plasma total homocysteine in male-to-female transsexuals.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Androstane-3,17-diol; Biomarkers; C-Reactive Protein; Creatinine; Cyproterone Acetate; Cysteine; Estradiol; Estrogens; Female; Fibrinogen; Folic Acid; Follicle Stimulating Hormone; Homocysteine; Humans; Luteinizing Hormone; Male; Middle Aged; Randomized Controlled Trials as Topic; Serum Albumin; Statistics as Topic; Testosterone; Time Factors; Transsexualism | 2003 |
6 other study(ies) available for cyproterone acetate and androstane-3,17-diol
| Article | Year |
|---|---|
Androstanediolglucuronide: a parameter for peripheral androgen activity before and during therapy with cyproterone acetate.
Topics: Androgen Antagonists; Androgens; Androstane-3,17-diol; Cyproterone; Cyproterone Acetate; Female; Hirsutism; Humans; Polycystic Ovary Syndrome | 1991 |
Is plasma 5 alpha-androstane 3 alpha, 17 beta-diol glucuronide a biochemical marker of hirsutism in women?
Topics: Adult; Androgen Antagonists; Androstane-3,17-diol; Biomarkers; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Hirsutism; Humans; Middle Aged; Polycystic Ovary Syndrome | 1991 |
Metabolic effect at six and twelve months of cyproterone acetate (2 mg) combined with ethinyl estradiol (35 micrograms) in 31 patients.
Topics: Adolescent; Adult; Androgens; Androstane-3,17-diol; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Lipoproteins; Triglycerides | 1990 |
Interactions of an anti-androgen (cyproterone acetate) with the androgen receptor system and its biological action in the rat ventral prostate.
Topics: Androgen Antagonists; Androstane-3,17-diol; Animals; Cyproterone; Cyproterone Acetate; Cytosol; Dihydrotestosterone; Estrenes; Male; Metribolone; Prostate; Rats; Rats, Inbred Strains; Receptors, Androgen; Receptors, Steroid; Testosterone | 1985 |
Androgen levels during cyproterone acetate and ethinyl oestradiol treatment of hirsutism.
Topics: Adolescent; Adult; Androgens; Androstane-3,17-diol; Androstenediol; Androstenedione; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Ethinyl Estradiol; Female; Hirsutism; Humans; Sex Hormone-Binding Globulin; Testosterone | 1984 |
The organ culture of hunan epididymal tubules and their response to androgens.
Topics: Adult; Aged; Amino Acids; Androgens; Androstane-3,17-diol; Contraceptive Agents, Male; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Epididymis; Humans; Male; Middle Aged; Organ Culture Techniques; Testosterone; Thymidine | 1981 |